About: New insights in cardiac structural changes in patients with Fabry’s disease

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: New insights in cardiac structural changes in patients with Fabry’s disease Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в червні 2000 (uk) article scientifique publié en juin 2000 (fr) im Juni 2000 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q57848053-486032CB-6C9F-4235-ACA8-A21138B3EC7D
publication date	2000-06-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q57848053-C7D1B64F-F375-4A6B-A177-E546DEF2A9E5
language of work or name	English
author name string	wds:Q57848053-14AEAA62-6901-4C0D-A8DA-93F037EB789C wds:Q57848053-236D1189-FA65-4094-9445-B57FD757D514 wds:Q57848053-2ED351C1-1B9A-4B60-AA07-E90A7A002D4B wds:Q57848053-5910FA0D-F031-47DA-89FC-61EB84D0FF6D wds:Q57848053-5A3AB0AC-3E2D-4E4D-AB33-ADC93896DFA0 wds:Q57848053-8FB0F20D-9859-4497-B004-990531183B1E wds:Q57848053-A912C717-71E5-479C-93A3-486508A607E3 wds:Q57848053-C7912626-B036-48B7-A155-EA36A7A5D3C6 wds:Q57848053-EC71B803-8439-4C8A-9799-3B838A606DBF wds:Q57848053-FA4AC066-08FC-422D-B4FC-4E9C40471D4D
author name string	Aleš Linhart Michael Aschermann Milan Elleder Jan Bultas Helena Poupětová Debora Karetová Tomáš Paleček James J. Ferguson Jiři Zeman Jana Hrudová
rdfs:label	New insights in cardiac structural changes in patients with Fabry’s disease (en) New insights in cardiac structural changes in patients with Fabry’s disease (nl)
skos:prefLabel	New insights in cardiac structural changes in patients with Fabry’s disease (en) New insights in cardiac structural changes in patients with Fabry’s disease (nl)
name	New insights in cardiac structural changes in patients with Fabry’s disease (en) New insights in cardiac structural changes in patients with Fabry’s disease (nl)
author	wds:Q57848053-601604BF-8B87-43F4-8357-CB2A88A54115
author	Jana Ledvinová
title	wds:Q57848053-2B44344C-988A-464D-B773-1383581444E1
title	New insights in cardiac structural changes in patients with Fabry’s disease (en)
page(s)	wds:Q57848053-0D3A26B3-348D-49AD-A071-E187D7FF44FB
page(s)	1101-1108
instance of	wds:Q57848053-E2AA0E98-1209-40A1-B0EC-63E71EE98B95
instance of	scholarly article
main subject	wds:Q57848053-C685CEB3-A218-48DB-A6C5-3A0A88A240B4 wds:Q57848053-E27485B4-C86B-4B9E-815B-6924055E6F51
main subject	Fabry disease Patients
PubMed ID	wds:Q57848053-00F4AEFA-047F-4F2F-9F65-949E3EB93DB5
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10827394
PubMed ID	10827394
published in	wds:Q57848053-3A04B039-032C-4DB6-B7F5-7AAB8010B4A8
published in	American Heart Journal
issue	wds:Q57848053-346B6E36-345D-4573-AC68-A84BDB567A1A
volume	wds:Q57848053-0CF1034D-15A6-4C21-8FEA-1E9B18643633
issue	6
volume	139
DOI	wds:Q57848053-4D8CBDEF-20B5-4A77-8C0D-D76EA9C08F5D
DOI	http://dx.doi.org/10.1067/MHJ.2000.105105
DOI	10.1067/MHJ.2000.105105
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q57848053
is cites work of	Cardiac abnormalities in Anderson-Fabry disease and Fabry's cardiomyopathy Twenty-four-month alpha-galactosidase A replacement therapy in Fabry disease has only minimal effects on symptoms and cardiovascular parameters Anderson-Fabry disease: long-term echocardiographic follow-up under enzyme replacement therapy Improvement in serial cardiopulmonary exercise testing following enzyme replacement therapy in Fabry disease Clinical benefit of enzyme replacement therapy in Fabry disease Fabry disease Reduced coronary flow reserve in Anderson-Fabry disease measured by transthoracic Doppler echocardiography Fabry disease: guidelines for the evaluation and management of multi-organ system involvement Patients affected with Fabry disease have an increased incidence of progressive hearing loss and sudden deafness: an investigation of twenty-two hemizygous male patients. Treatment of lysosomal storage disorders : progress with enzyme replacement therapy The heart in Anderson-Fabry disease and other lysosomal storage disorders. The pathology of hypertrophic cardiomyopathy Cardiovascular manifestations of Fabry disease: relationships between left ventricular hypertrophy, disease severity, and alpha-galactosidase A activity Monitoring the clinical and biochemical response to enzyme replacement therapy in three children with Fabry disease Cardiac manifestations in Fabry disease Continuous cardiac troponin I release in Fabry disease Cardiac manifestations of Anderson-Fabry disease in heterozygous females Effectiveness of agalsidase alfa enzyme replacement in Fabry disease: cardiac outcomes after 10 years' treatment Normal left-atrial structure and function despite concentric left-ventricular remodelling in a cohort of patients with Anderson-Fabry disease Anderson-Fabry cardiomyopathy: prevalence, pathophysiology, diagnosis and treatment The expanding clinical spectrum of Anderson-Fabry disease: a challenge to diagnosis in the novel era of enzyme replacement therapy. Natural history of the respiratory involvement in Anderson-Fabry disease. Enzyme replacement therapy improves cardiac features and severity of Fabry disease Fabry disease: Diagnosis and treatment The role of echocardiographic deformation imaging in hypertrophic myopathies. Cardiovascular magnetic resonance demonstration of the spectrum of morphological phenotypes and patterns of myocardial scarring in Anderson-Fabry disease Genetic polymorphisms of vitamin D receptor (VDR) in Fabry disease Two-dimensional speckle tracking echocardiography for early detection of myocardial damage in young patients with Fabry disease. Fabry disease: a functional and anatomical study of cardiac manifestations in 20 hemizygous male patients. Prevalence of Fabry disease in male patients with unexplained left ventricular hypertrophy in primary cardiology practice: prospective Fabry cardiomyopathy screening study (FACSS). Late-onset primary LVH HCM versus cardiac fabry variant Chloroquine cardiotoxicity: clinicopathologic features in three patients and comparison with three patients with Fabry disease Study of urinary proteomes in Anderson-Fabry disease Sex differences in cardiomyopathies Electrical Changes in Resting, Exercise, and Holter Electrocardiography in Fabry Cardiomyopathy Misleading terms in Anderson-Fabry disease. Early cardiac changes in children with anderson-fabry disease [Neurological aspects of Fabry's disease]. A case of fabry cardiomyopathy X-linked inheritance and its implication in the diagnosis and management of female patients in Fabry disease

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 171 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software